Introduction Drug shortages of long-acting GLP-1 receptor agonists and dual GLP-1/GIP receptor agonist have emerged unexpectedly and persisted through the first quarter of 2023
The relationship between sleep quality and daytime physical and cognitive performance creates a positive feedback loop: better sleep supports improved training capacity and recovery, while appropriate training and hormone optimization enhance sleep quality, collectively contributing to overall health and performance optimization
How the study was designed Included adults 18 to 65 with type 2 diabetes who were newly prescribed one of three drug types: a GLP-1 receptor agonist (161,489 people), an SGLT-2 inhibitor (122,114 people), or a DPP-4 inhibitor (86,047 people)
A unique factor behind its dominance is the ability of specialty clinics to offer customized IV glutathione regimens tailored to individual wellness and aesthetic goals, supported by dedicated medical professionals and advanced infusion management systems, which enhance patient satisfaction and treatment outcomes
yes Controlled substance
Press release, 11 December 2025
